Brief: Y-Mabs Appoints Doug Gentilcore As Head Of Danyelza Unit
10/01/2025 12:42
Jan 10 (Reuters) - Y-mAbs Therapeutics Inc YMAB.O :
* Y-MABS APPOINTS EXPERIENCED COMMERCIAL LEADER AS HEAD OF
DANYELZA BUSINESS UNIT
Source text: urn:newsml:reuters.com:*:nGNX9RSVTT
Further company coverage: YMAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary